IRLAB Therapeutics: Funding, Investors & Team (Sep 2026)
IRLAB is a Swedish drug discovery and development company providing novel treatments for disorders of the brain. IRLAB is engaged in programmes targeting core dysfunctions in Parkinson’s disease and dementias. IRLAB has identified, and is currently engaged in clinical development of, two novel compounds aimed at offering improved clinical benefit for patients with Parkinson’s disease.
IRLAB Therapeutics has raised $11.0M across 1 funding round on record, the most recent an undisclosed round of $11.0M announced in May 2026.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
IRLAB Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2026.
IRLAB Therapeutics Funding Rounds
IRLAB Therapeutics Founders and Leadership Team
Contact details for the IRLAB Therapeutics team: 1 has a LinkedIn profile.
Start 14-day free trial →IRLAB Therapeutics Funding Compared to Other Health Care Startups
IRLAB Therapeutics' latest round of $11.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like IRLAB Therapeutics in Health Care and Göteborg
Companies Similar to IRLAB Therapeutics
Neko Health, a health-tech company from Sweden, aims to develop a healthcare system that promotes the…
Celluminova specializes in the development of new tools for stem cell research, including cancer stem cells.
Klaria (Klaria Pharma Holding AB) is a Swedish listed pharmaceutical company that develops innovative,…
ChemoTech is a Scandinavian company based at Medicon Village in Lund, Sweden. The company’s founders have…
Spermosens is a medical equipment manufacturer that produces technologies for diagnosing male-factor…
The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD, AD and…
Blodtrycksdoktorn is an evidence-based digital innovation that uses telemedicine, mobile health technology,…
B! BB Instruments develops an instrument that allows quick and easy sampling of suspected cancer tumors by…
Observe Medical has developed a revolutionary digital urine meter - Sippi. Sippi is an easy-to-use…
Beactica Therapeutics AB is a precision oncology company committed to the fight against cancer. The company…
Loovi is a health technology firm that provides a doctor-led, data-driven longevity solution. It focuses on…
Yazen is a digital healthcare provider that offers tailored weight loss programs, combining medical…
IRLAB Therapeutics Funding FAQs
What does IRLAB Therapeutics do?
IRLAB is a Swedish drug discovery and development company providing novel treatments for disorders of the brain. IRLAB is engaged in programmes targeting core dysfunctions in Parkinson’s disease and dementias. IRLAB has identified, and is currently engaged in clinical development of, two novel compounds aimed at offering improved clinical benefit for patients with Parkinson’s disease.
How much funding has IRLAB Therapeutics raised?
IRLAB Therapeutics has raised $11.0M across 1 round on record. The most recent is an undisclosed round of $11.0M announced in May 2026.
When did IRLAB Therapeutics last raise funding?
IRLAB Therapeutics' most recent funding round on record is an undisclosed round of $11.0M, announced in May 2026.
Who founded IRLAB Therapeutics?
FundedIQ lists Kristina Torfgard (Founder) at IRLAB Therapeutics.
Where is IRLAB Therapeutics headquartered?
IRLAB Therapeutics is based in Göteborg, Vastra Gotaland, Sweden.
How many employees does IRLAB Therapeutics have?
IRLAB Therapeutics is in the 11-50 employee band.
How does IRLAB Therapeutics' funding compare to other Health Care startups?
IRLAB Therapeutics' latest round of $11.0M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's IRLAB Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for IRLAB Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.